Harbor MedTech, Inc. Their patented BriDGE® technology is the heart of their innovative products and services. By transforming readily available Type-1 collagen into a bio-friendly and stabilized collagen matrix, their technology triggers the patient's own healing cascade.

Through pre-clinical and clinical experience, it has been demonstrated that Harbor MedTech's BriDGE-processed collagen matrix accelerates wound healing, activates and supports tissue regeneration, and limits the formation of scar tissue and infectious biofilm. Their FDA-cleared and CE marked products, along with a robust pipeline, leverage their patented BriDGE® Collagen Processing Technology. The company's product pipeline primarily focuses on Orthobiologic Soft Tissue (Sports Medicine) injuries, General Surgical Repair of Hernia and Breast Reconstruction, and Difficult to Heal Chronic Skin Wounds.

For more information about Harbor MedTech and their groundbreaking regenerative medicine solutions, please contact them at (949) 525-3601 or reach out to Jerry Mezgar, the President, and Chief Executive Officer, at JerryM@HarborMedTech. com